AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn which credit card has no annual fee and offers the best benefits for your spending habits. Make a smart choice!
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
UBS uMINT yield-bearing collateral is now live on Bybit through a three‑party workflow, turning idle cash into produc...
DeXe shows resilience as on-chain activity climbs and wallet growth accelerates amid a broader market downturn. Analy...
As XRP tests new volatility, investors debate shocking ripple price predictions that span from modest gains to outsiz...
A CNBC analyst contends the FedEx selloff reflects misinterpretation of the income statement, not a collapse in deman...
XRP is flashing warnings on-chain as sellers keep control, with Open Interest near lows and outflows signaling fading...
Vanguard’s FTSE Emerging Markets ETF (VWO) omits South Korea due to a 2009 reclassification, leaving investors expose...
Bitcoin stabilizes after a sharp pullback, but traders warn that reclaiming a key level is essential to avoiding rene...
Graduates entering May 2026 face a louder AI-driven job scare than cheers. This report examines how the sound graduat...
A surge of fear, uncertainty, and doubt sweeps social feeds as Ethereum faces ETF-driven volatility. This report brea...
BP's board removed Albert Manifold as chair and another director amid governance concerns raised to the board. The mo...
As the Fed stays steady on rates, investors debate whether crypto should be bought before or after the next rate cut....